BridgeMD
New treatment option for Urinary Incontinence (UI)
Official title Reducing Disparities in Urinary Control Symptoms for Minority Women
ClinicalTrials.gov ID: NCT06798311
What this study is testing
- What it's testing
- The study is designed to address the disparity in available conservative/behavioral treatments for UI/LUTS. The program was developed by experts from urogynecology, psychology, and physical therapy then modified based on focus group feedback from racially minoritized women.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- Age 18 years or older
- Able to converse in English
- A response of at least "somewhat bothered" by urinary incontinence, urinary frequency or urgency on the UDI
- Willing to engage in conservative treatment of their UI/LUTS for 16 weeks
You likely can't join if
- Anterior or posterior pelvic organ prolapse beyond the hymen or apical prolapse to the hymen
- Currently taking medications for their UI/LUTS or history of surgical intervention for UI
- Patients with abnormal PVR and positive urine culture at time of study entry
- History of recurrent UTIs
- History of mobility or neurologic disorders that would prevent ability to complete at home physical therapy
- Planning to start PT within the next 16 weeks
The study team makes the final eligibility decision.
Where it's taking place
- Chicago, Illinois, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chicago, Illinois, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.